NOVAVAX INC (NVAX) Forecast, Price Target & Analyst Ratings

NASDAQ:NVAX • US6700024010

Current stock price

8.84 USD
+0.2 (+2.31%)
At close:
8.8789 USD
+0.04 (+0.44%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVAVAX INC (NVAX).

Forecast Snapshot

Consensus Price Target

Price Target
$13.39
+ 51.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.24
Revenue Estimate
80.96M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
73.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.39
Upside
+ 51.44%
From current price of $8.84 to mean target of $13.39, Based on 15 analyst forecasts
Low
$7.07
Median
$12.24
High
$26.25

Price Target Revisions

1 Month
1.83%
3 Months
2.72%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for NVAX. The average price target is 13.39 USD. This implies a price increase of 51.44% is expected in the next year compared to the current price of 8.84.
The average price target has been revised upward by 2.72% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NVAX Current Analyst RatingNVAX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

NVAX Historical Analyst RatingsNVAX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
73.33%
NVAX was analyzed by 15 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about NVAX.
In the previous month the buy percentage consensus was at a similar level.
NVAX was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-27HC Wainwright & Co.Maintains Buy -> Buy
2026-01-20BTIGReiterate Buy -> Buy
2025-11-18JP MorganMaintains Underweight -> Underweight
2025-11-10B. Riley SecuritiesReiterate Buy -> Buy
2025-11-04TD CowenMaintains Hold -> Hold
2025-10-24Cantor FitzgeraldInitiate Overweight
2025-10-23HC Wainwright & Co.Maintains Buy -> Buy
2025-08-20B of A SecuritiesDowngrade Neutral -> Underperform
2025-07-22B of A SecuritiesMaintains Neutral -> Neutral
2025-06-17CitigroupInitiate Sell
2025-05-09JP MorganMaintains Underweight -> Underweight
2024-12-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-16JefferiesMaintains Buy -> Buy
2024-10-10B. Riley SecuritiesReiterate Buy -> Buy
2024-10-02JefferiesMaintains Buy -> Buy
2024-08-12B. Riley SecuritiesReiterate Buy -> Buy
2024-08-12JP MorganMaintains Underweight -> Underweight
2024-08-02B. Riley SecuritiesMaintains Buy -> Buy
2024-07-30JP MorganDowngrade Neutral -> Underweight
2024-06-14B of A SecuritiesMaintains Neutral -> Neutral
2024-05-23B. Riley SecuritiesMaintains Buy -> Buy
2024-05-13TD CowenMaintains Hold -> Hold
2024-05-13HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.24
Revenue Estimate
80.96M
Revenue Q2Q
-87.86%
EPS Q2Q
-108.12%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
0.08%
Revenue (3 Months)
-22.54%
EPS (1 Month)
2.78%
EPS (3 Months)
-19.66%

Next Earnings Summary

NVAX is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.24 USD and the consensus revenue estimate is 80.96M USD.
The next earnings revenue estimate has been revised downward by 22.54% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NVAX revenue by date.NVAX revenue by date.
983.705M
-50.37%		682.162M
-30.65%		1.123B
64.69%		402.75M
-64.15%		296.79M
-26.31%		363.31M
22.41%		370.58M
2.00%		452.9M
22.21%		592.4M
30.80%		707.53M
19.43%		1.081B
52.79%
EBITDA
YoY % growth
NVAX ebitda by date.NVAX ebitda by date.
-510.986M
16.99%		-183.435M
64.10%		590.853M
422.10%		-24.662M
-104.17%		-50.208M
-103.58%		-46.28M
7.82%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
NVAX ebit by date.NVAX ebit by date.
-552.211M
14.35%		-231.931M
58.00%		563.24M
342.85%		-47.52M
-108.44%		-27.052M
43.07%		80.814M
398.73%		90.407M
11.87%		172.52M
90.83%		315.55M
82.91%		425.4M
34.81%		734.11M
72.57%
Operating Margin
NVAX operating margin by date.NVAX operating margin by date.
-56.14%-34.00%50.13%-11.80%-9.12%22.24%24.40%38.09%53.27%60.12%67.91%
EPS
YoY % growth
NVAX eps by date.NVAX eps by date.
-5.53
34.17%		-1.65
70.16%		2.41
246.06%		-0.41
-116.95%		-0.17
59.29%		0.39
333.44%		0.48
23.52%		0.52
8.51%		0.18
-64.71%		0.34
83.33%		3.61
972.73%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.24
-108.12%		-0.11
-117.55%		-0.08
93.34%		0.01
-87.64%		-0.43
-80.00%		-0.36
-228.11%		1.06
1,373.42%		0.47
3,350.86%
Revenue
Q2Q % growth		80.96M
-87.86%		88.86M
-62.86%		135.02M
91.67%		141.04M
-4.15%		12.961M
-83.99%		10.704M
-87.95%		266.82M
97.62%		151.13M
7.15%
EBITDA
Q2Q % growth		-35.123M
-106.70%		-61.921M
-150.93%		15.85M
127.86%		66.42M
36.81%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-32.066M
-106.21%		-12.911M
-112.22%		9.479M
111.94%		20.99M
0.25%		-78.439M
-144.61%		-70.18M
-443.57%		193.15M
1,937.66%		80.768M
284.79%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NVAX Yearly Revenue VS EstimatesNVAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
NVAX Yearly EPS VS EstimatesNVAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-45.59%
EPS Next 5 Year
-26.41%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-30.54%
Revenue Next 5 Year
-16.02%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-28.29%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NOVAVAX INC / NVAX Forecast FAQ

What do analysts expect the price target to be for NOVAVAX INC (NVAX)?

15 analysts have analysed NVAX and the average price target is 13.39 USD. This implies a price increase of 51.44% is expected in the next year compared to the current price of 8.84.

What is the next earnings date for NVAX stock?

NOVAVAX INC (NVAX) will report earnings on 2026-05-13.

Can you provide the consensus estimates for NOVAVAX INC next earnings?

The consensus EPS estimate for the next earnings of NOVAVAX INC (NVAX) is -0.24 USD and the consensus revenue estimate is 80.96M USD.

What is the consensus rating for NVAX stock?

The consensus rating for NOVAVAX INC (NVAX) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.